|
|
Prepublished online as a Blood First Edition Paper on June 21, 2002; DOI 10.1182/blood-2002-03-0902.

Submitted March 22, 2002
Accepted May 15, 2002
Platelets, circulating tissue factor, and fibrin colocalize in ex-vivo thrombi: Real-time fluorescence images of thrombus formation and propagation under defined flow conditions
Viji Balasubramanian, Eric Grabowski, Alessandra Bini, and Yale Nemerson*
Thrombosis Research, Mount Sinai School of Medicine, New York, NY, USA
Cardiovascular Thrombosis Laboratory, Massachusetts General Hospital-Harvard Medical School, Boston, MA, USA
New York Blood Center and Department of Pathology, Columbia University College of Physicians and Surgeons, New York, New York, NY, USA
* Corresponding author; email: Yale.Nemerson{at}mssm.edu.
While it is generally accepted that the initial event in coagulation and intravascular thrombus formation is the exposure of tissue factor (TF) to blood, there is still little agreement about the mechanisms of thrombus propagation and the identities of the molecular species participating in this process. In this study, we characterized the thrombotic process in real-time and under defined flow conditions, in order to determine the relative contribution and spatial distribution of three components of the thrombi: circulating or blood-borne TF (cTF), fibrin, and platelets. For this purpose, we utilized high-sensitivity, multi-color immunofluorescence microscopy coupled with a laminar flow chamber. Freshly drawn blood, labeled with mepacrine (marker for platelets and white cells), anti-hTF1Alexa 568(marker for tissue factor), and anti-T2G1Cy-5 (marker for fibrin) was perfused over collagen-coated glass slides at wall shear rates of 100 and 650 s-1. A motorized filter cube selector facilitated imaging every 5 seconds at one of 3 different wavelengths, corresponding to optimal wavelengths for the 3 markers above. Real-time video recordings obtained during 10 discrete experiments show rapid deposition of platelets and fibrin onto collagen-coated glass. Overlay images of platelets, fibrin, and cTF clearly demonstrate co-localization of these three components in growing thrombi. These data further support our earlier observations that, in addition to TF present in the vessel wall, there is a pool of TF in circulating blood that contributes to the propagation of thrombosis at a site of vascular injury.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Orfeo, K. E. Brummel-Ziedins, M. Gissel, S. Butenas, and K. G. Mann
The Nature of the Stable Blood Clot Procoagulant Activities
J. Biol. Chem.,
April 11, 2008;
283(15):
9776 - 9786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Nurden
Platelets and Tissue Remodeling: Extending the Role of the Blood Clotting System
Endocrinology,
July 1, 2007;
148(7):
3053 - 3055.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Hathcock
Flow Effects on Coagulation and Thrombosis
Arterioscler Thromb Vasc Biol,
August 1, 2006;
26(8):
1729 - 1737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cho and D. F. Mosher
Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi
Blood,
May 1, 2006;
107(9):
3555 - 3563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Touat, V. Ollivier, J. Dai, M.-G. Huisse, A. Bezeaud, U. Sebbag, T. Palombi, P. Rossignol, O. Meilhac, M.-C. Guillin, et al.
Renewal of Mural Thrombus Releases Plasma Markers and Is Involved in Aortic Abdominal Aneurysm Evolution
Am. J. Pathol.,
March 1, 2006;
168(3):
1022 - 1030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Thattaliyath, M. Cykowski, and P. Jagadeeswaran
Young thrombocytes initiate the formation of arterial thrombi in zebrafish
Blood,
July 1, 2005;
106(1):
118 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Coller
Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality: Is It Time to Intervene?
Arterioscler Thromb Vasc Biol,
April 1, 2005;
25(4):
658 - 670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Butenas, B. A. Bouchard, K. E. Brummel-Ziedins, B. Parhami-Seren, and K. G. Mann
Tissue factor activity in whole blood
Blood,
April 1, 2005;
105(7):
2764 - 2770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Palmerini, B. S. Coller, V. Cervi, L. Tomasi, A. Marzocchi, C. Marrozzini, O. Leone, M. Piccioli, and A. Branzi
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system
J. Am. Coll. Cardiol.,
October 19, 2004;
44(8):
1570 - 1577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Aras, A. Shet, R. R. Bach, J. L. Hysjulien, A. Slungaard, R. P. Hebbel, G. Escolar, B. Jilma, and N. S. Key
Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia
Blood,
June 15, 2004;
103(12):
4545 - 4553.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Dietzen, K. L. Page, and T. A. Tetzloff
Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity
Blood,
April 15, 2004;
103(8):
3038 - 3044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Tutar, M. Ozcan, M. Kilickap, S. Gulec, O. Aras, G. Pamir, D. Oral, L. Dandelet, and N. S. Key
Elevated Whole-Blood Tissue Factor Procoagulant Activity as a Marker of Restenosis After Percutaneous Transluminal Coronary Angioplasty and Stent Implantation
Circulation,
September 30, 2003;
108(13):
1581 - 1584.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|